AGL 40.00 Decreased By ▼ -0.21 (-0.52%)
AIRLINK 127.00 Decreased By ▼ -0.64 (-0.5%)
BOP 6.70 Increased By ▲ 0.03 (0.45%)
CNERGY 4.50 Increased By ▲ 0.05 (1.12%)
DCL 8.65 Decreased By ▼ -0.08 (-0.92%)
DFML 41.02 Decreased By ▼ -0.14 (-0.34%)
DGKC 85.40 Decreased By ▼ -0.71 (-0.82%)
FCCL 33.05 Increased By ▲ 0.49 (1.5%)
FFBL 66.20 Increased By ▲ 1.82 (2.83%)
FFL 11.56 Decreased By ▼ -0.05 (-0.43%)
HUBC 111.22 Decreased By ▼ -1.24 (-1.1%)
HUMNL 14.84 Increased By ▲ 0.03 (0.2%)
KEL 5.14 Increased By ▲ 0.10 (1.98%)
KOSM 7.59 Increased By ▲ 0.23 (3.13%)
MLCF 40.21 Decreased By ▼ -0.12 (-0.3%)
NBP 60.50 Decreased By ▼ -0.58 (-0.95%)
OGDC 194.30 Increased By ▲ 0.12 (0.06%)
PAEL 26.66 Decreased By ▼ -0.25 (-0.93%)
PIBTL 7.39 Increased By ▲ 0.11 (1.51%)
PPL 153.92 Increased By ▲ 1.24 (0.81%)
PRL 26.18 Decreased By ▼ -0.04 (-0.15%)
PTC 17.15 Increased By ▲ 1.01 (6.26%)
SEARL 85.51 Decreased By ▼ -0.19 (-0.22%)
TELE 7.56 Decreased By ▼ -0.11 (-1.43%)
TOMCL 34.24 Decreased By ▼ -2.23 (-6.11%)
TPLP 8.89 Increased By ▲ 0.10 (1.14%)
TREET 16.80 Decreased By ▼ -0.04 (-0.24%)
TRG 62.50 Decreased By ▼ -0.24 (-0.38%)
UNITY 27.30 Decreased By ▼ -0.90 (-3.19%)
WTL 1.30 Decreased By ▼ -0.04 (-2.99%)
BR100 10,110 Increased By 24.6 (0.24%)
BR30 31,193 Increased By 23.3 (0.07%)
KSE100 95,031 Increased By 267.8 (0.28%)
KSE30 29,482 Increased By 72.1 (0.25%)
World

ADB approves $450mn loan for Indonesia COVID-19 vaccinations

  • The loan will fund the purchase of at least 65 million doses of COVID-19 vaccines for priority groups determined.
Published March 31, 2021

JAKARTA: The Asian Development Bank (ADB) has approved a $450 million loan to Indonesia to help the country's state firm Bio Farma to procure and distribute COVID-19 vaccines, the Manila-based lender said in a statement.

The loan will fund the purchase of at least 65 million doses of COVID-19 vaccines for priority groups determined by the Indonesian government, the bank said, adding that it was part of its $9 billion Asia Pacific Access Facility programme for developing members.

Comments

Comments are closed.